Isoliquiritin treatment of osteoporosis by promoting osteogenic differentiation and autophagy of bone marrow mesenchymal stem cells
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Zhikang Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guan…. Hauptthemen laut MEDLINE: Osteoporosis, Mesenchymal Stem Cells, Glucosides. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Guangdong Provincial Science and Technology Plan Project, Key Projects of Science and Technology Plan of Liwan District of Guangzhou City, Research and Development Plan of Key Areas of Scientific Research Institutions in Guangdong Province.
Abstract (Originalsprache)
Osteoporosis is a chronic progressive bone disease characterized by the decreased osteogenic ability of osteoblasts coupled with increased osteoclast activity. Natural products showing promising therapeutic potential for postmenopausal osteoporosis remain underexplored. In this study, we aimed to analyze the therapeutic effects of isoliquiritin (ISL) on osteoporosis in mice and its possible mechanism of action. An ovariectomy‐induced osteoporosis mouse model and bone marrow mesenchymal stem cells (BMSCs) were used to analyze the effects of ISL on bone regeneration in vivo and in vitro, respectively. Mitogen‐activated protein kinase (MAPK) and autophagy inhibitors were used, to investigate whether the MAPK signaling pathway and autophagy affect the osteogenic differentiation of BMSCs. ISL significantly improved bone formation and reduced bone resorption in mouse femurs without inducing any detectable toxicity in critical organs such as the liver, kidney, brain, heart, and spleen. In vitro experiments showed that ISL enhanced the proliferation and osteogenic differentiation of BMSCs and that its osteogenic effect was attenuated by p38/extracellular regulated protein kinase (ERK) and autophagy inhibitors. Further studies showed that the inhibition of phosphorylated p38/ERK blocked ISL autophagy in BMSCs. ISL promoted the osteogenic differentiation of BMSCs through the p38/ERK‐autophagy pathway and was therapeutically effective in treating osteoporosis in ovariectomized mice without any observed toxicity to vital organs. These results strongly suggest the promising potential of ISL as a safe and efficacious candidate drug for the treatment of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Prosthodontics, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerativ…
- Department of Dentistry and Endodontics, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral…
ORCID-Profile: Lvhua Guo
Förderung
- Guangdong Provincial Science and Technology Plan Project
- Key Projects of Science and Technology Plan of Liwan District of Guangzhou City
- Research and Development Plan of Key Areas of Scientific Research Institutions in Guangdong Province
- Key Technology Research and Development of Oral High-Performance Implantable Medical Devices
Zitieren
APA
Su, Z., Chen, D., Huang, J., Liang, Z., Ren, W., Zhang, Z., Jiang, Q., Luo, T., & Guo, L. (2024). Isoliquiritin treatment of osteoporosis by promoting osteogenic differentiation and autophagy of bone marrow mesenchymal stem cells. Phytotherapy Research. https://doi.org/10.1002/ptr.8032
Vancouver
Su Z, Chen D, Huang J, Liang Z, Ren W, Zhang Z, et al. Isoliquiritin treatment of osteoporosis by promoting osteogenic differentiation and autophagy of bone marrow mesenchymal stem cells. Phytotherapy Research. 2024. doi:10.1002/ptr.8032
BibTeX
@article{Su2024,
author = {Su, Zhikang and Chen, Ding and Huang, Jiangyon and Liang, Zitian and Ren, Wen and Zhang, Zeyu and Jiang, Qianzhou and Luo, Tao and Guo, Lvhua},
title = {Isoliquiritin treatment of osteoporosis by promoting osteogenic differentiation and autophagy of bone marrow mesenchymal stem cells},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8032}
}
EUVIMED